We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00484601
Recruitment Status : Terminated
First Posted : June 11, 2007
Last Update Posted : December 17, 2008
Sponsor:
Information provided by:
Sidney Kimmel Comprehensive Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Estimated Study Completion Date : September 2010